Screener
Veracyte VCYT Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $299.52M+35.4% | $264.79M+41.0% | $364.23M+51.4% | $317.21M+15.3% | $221.15M-6.7% | ||
| $54.18M+6.6% | $50.11M-6.8% | $44.66M-4.0% | $47.83M-2.0% | $50.81M+1.0% | ||
| $574.78M+38.6% | $522.18M+36.3% | $488.38M+31.2% | $449.22M+25.9% | $414.68M+29.1% | ||
| $21.93M+18.2% | $22.65M+0.5% | $22.19M-3.3% | $18.9M-10.8% | $18.55M-16.8% | ||
| $767.15M-0.8% | $767.15M+1.7% | $767.15M+2.9% | $767.15M+0.7% | $773.26M+2.8% | ||
| $82.7M-7.7% | $79.66M-6.9% | $82.95M-18.9% | $86.28M-9.5% | $89.61M-9.5% | ||
| —— | —— | $50.31M— | —— | —— | ||
| $1.49B+10.6% | $1.44B+9.2% | $1.41B+8.2% | $1.37B+7.3% | $1.34B+8.9% | ||
| $8.02M-29.9% | $6.91M-56.0% | $4.59M-46.8% | $5.51M-43.0% | $11.45M-5.3% | ||
| $597K-58.8% | $749K-56.3% | $1.16M-30.7% | $417K-79.5% | $1.45M-33.9% | ||
| $62.74M-17.9% | $56.12M-25.3% | $59.94M-23.8% | $72.15M+2.6% | $76.43M+5.7% | ||
| $97.96M-20.4% | $91.99M-23.6% | $96.44M-22.3% | $110.12M+11.3% | $123.05M+20.9% | ||
| 80K-99.9% | 125M0.0% | 125M+160,156% | 125M0.0% | 125M0.0% | ||
| -$323.43M+26.1% | -$348.92M+20.1% | -$377.63M+14.9% | -$418.78M+6.8% | -$437.92M+5.7% | ||
| $1.39B+13.7% | $1.34B+12.5% | $1.31B+11.4% | $1.26B+6.9% | $1.22B+7.8% | ||
| $1.49B+10.6% | $1.44B+9.2% | $1.41B+8.2% | $1.37B+7.3% | $1.34B+8.9% |
FAQ
- What are Veracyte's total assets?
- Veracyte (VCYT) holds $1.5B in total assets, up 10.6% year over year.
- How much debt does Veracyte have?
- Veracyte carries $40.1M in total debt against $1.4B of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Veracyte have?
- Veracyte holds $299.5M in cash and equivalents.
- Can Veracyte cover its short-term obligations?
- Its current ratio is 9.16 — current assets exceed current liabilities.
- Where does Veracyte's balance sheet data come from?
- Every line is extracted from Veracyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
